Attana Past Earnings Performance
Past criteria checks 0/6
Attana's earnings have been declining at an average annual rate of -13.3%, while the Life Sciences industry saw earnings growing at 26.7% annually. Revenues have been growing at an average rate of 3% per year.
Key information
-13.3%
Earnings growth rate
0.7%
EPS growth rate
| Life Sciences Industry Growth | 31.8% |
| Revenue growth rate | 3.0% |
| Return on equity | -77.4% |
| Net Margin | -186.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Attana makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 7 | -12 | 13 | 0 |
| 31 Mar 24 | 7 | -12 | 14 | 0 |
| 31 Dec 23 | 7 | -14 | 16 | 0 |
| 30 Sep 23 | 6 | -15 | 15 | 0 |
| 30 Jun 23 | 7 | -16 | 16 | 0 |
| 31 Mar 23 | 11 | -16 | 18 | 0 |
| 31 Dec 22 | 13 | -15 | 19 | 0 |
| 30 Sep 22 | 14 | -15 | 21 | 0 |
| 30 Jun 22 | 14 | -14 | 22 | 0 |
| 31 Mar 22 | 11 | -15 | 21 | 0 |
| 31 Dec 21 | 8 | -17 | 21 | 0 |
| 30 Sep 21 | 11 | -14 | 21 | 0 |
| 30 Jun 21 | 10 | -13 | 19 | 0 |
| 31 Mar 21 | 9 | -11 | 16 | 0 |
| 31 Dec 20 | 7 | -11 | 14 | 0 |
| 30 Sep 20 | 5 | -11 | 13 | 0 |
| 30 Jun 20 | 4 | -11 | 12 | 0 |
| 31 Mar 20 | 6 | -9 | 12 | 0 |
| 31 Dec 19 | 8 | -7 | 13 | 0 |
| 30 Sep 19 | 8 | -6 | 12 | 0 |
| 30 Jun 19 | 8 | -4 | 12 | 0 |
| 31 Mar 19 | 6 | -6 | 12 | 0 |
| 31 Dec 18 | 5 | -6 | 12 | 0 |
| 30 Sep 18 | 5 | -6 | 12 | 0 |
| 31 Dec 17 | 4 | -7 | 10 | 0 |
| 31 Dec 16 | 9 | -4 | 11 | 0 |
| 30 Jun 16 | 6 | -3 | 8 | 0 |
| 30 Jun 15 | 5 | -2 | 8 | 0 |
| 30 Jun 14 | 3 | -2 | 6 | 0 |
Quality Earnings: ATANA is currently unprofitable.
Growing Profit Margin: ATANA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ATANA is unprofitable, and losses have increased over the past 5 years at a rate of 13.3% per year.
Accelerating Growth: Unable to compare ATANA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ATANA is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-13%).
Return on Equity
High ROE: ATANA has a negative Return on Equity (-77.4%), as it is currently unprofitable.